A study led by researchers from MD Anderson Cancer Center shows that radiation or surgical removal of metastatic tumors provides a major survival advantage for lung cancer patients with minimal stage IV disease who have not progressed after frontline chemotherapy.
To access this subscriber-only content please log in or renew your subscription.
Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.
Login Subscribe
Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.
Login Subscribe